Skip to content

To evaluate the safety and efficacy of Oxylife Aloevera Gel Bleach in imparting skin fairness and luminance in healthy female volunteers of varied skin types (Oily, Dry, Normal and Combination).

A phase IV, open label, monocentric, single arm clinical study to evaluate the safety and efficacy of Oxylife Aloevera Gel Bleach in imparting skin fairness and luminance in healthy female volunteers of varied skin types (Oily, Dry, Normal and Combination). - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/04/003523
Enrollment
35
Registered
2013-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Oxylife Aloevera Gel Bleach: application of product for bleaching the entire face and neck of each subject. Dose- only at visit 2 bleaching will be done. Duration- 7 days for each subje

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female Adult Subjects in general good health as determined from a recent medical history. • Subjects in the age group of 18 years and above. • Subject with Fitzpatrick skin types III to V. • Subjects willing to give a voluntary written informed consent and agree to come for regular follow up. • Subjects willing to abide by and comply with the study protocol. • Subjects who have not participated in a similar investigation in the past four weeks. Subjects who are willing not to participate in any other clinical trial during participation in the current trial. • Subjects with hyperpigmentation spots such as ephilides, lentigines, melasma, PIH will also be included in the study. • In addition, female subjects selected for the study must: • Be using a medically acceptable form of birth control for the duration of the study as judged by the investigator(s) Or • Be surgically sterile Or • Be post menopausal for at least 1 year • Have a negative urine pregnancy test upon check-in to the study facility. • Have a negative skin sensitivity test

Exclusion criteria

Exclusion criteria: Subjects who have: • Systolic blood pressure less than 90 mm of Hg and more than 140 mm of Hg • Diastolic blood pressure less than 60 mm of Hg and more than 90 mm of Hg. Minor deviations (2-4 mm Hg) at check-in may be acceptable at the discretion of the physician /investigator. • Pulse rate below 60 / minute and above 100/minute. • Respiratory rate below 14 or above18 breath per minute. • Oral temperature less than 96.2oF, more than 99.8oF.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Oxylife Aloevera Gel Bleach in imparting skin fairness and luminance in healthy female volunteers of varied skin types (Oily, Dry, Normal and Combination) in comparison to baseline.Timepoint: 7 days for each subject

Secondary

MeasureTime frame
To evaluate the safety of Oxylife Aloevera Gel Bleach. To evaluate the efficacy of Oxylife Aloevera Gel Bleach in imparting skin Hydration.Timepoint: 7 days for each subject

Countries

India

Contacts

Public ContactDr Mukesh Ramnane

MS Clinical Research Pvt Ltd.

mukesh.ramnane@mscr.in918040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026